Adverts

Open Access Articles- Top Results for Ontuxizumab

Ontuxizumab

</th></tr>
Ontuxizumab?
Monoclonal antibody
Source Chimeric/humanized hybrid (mouse/human)
Target TEM1
Clinical data
Identifiers
946415-62-9
None
Chemical data
Formula C6532H10050N1726O2054S44
147.0 kDa

Ontuxizumab[1] is a monoclonal antibody designed for the treatment of cancer.[2] It binds to TEM1.

This drug was developed by Morphotek, Inc.

References

  1. ^ World Health Organization (2013). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 109" (PDF). WHO Drug Information 27 (2). 
  2. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Evolocumab, American Medical Association.

Lua error in package.lua at line 80: module 'Module:Buffer' not found.